Organization
Kitasato University School of Medicine, Kanagawa, Japan
1 abstract
Abstract
A PHASE 1, SINGLE AND MULTIPLE ASCENDING DOSE STUDY OF TAS5315—A NOVEL HIGHLY SELECTIVE INHIBITOR OF BRUTON’S TYROSINE KINASE—IN HEALTHY MALE VOLUNTEERSOrg: Kitasato University School of Medicine, Kanagawa, Japan, University of Occupational and Environmental Health, Kitakyushu, Japan, Keio University School of Medicine, Keio University School of Medicine, Japan,